Effects of exenatide on urinary albumin in overweight/obese patients with T2DM: a randomized clinical trial

In this study, we investigated the effect of exenatide (EXE), a glucagon-like peptide (GLP)-1 receptor agonist, on kidney function, obesity indices, and glucose control in overweight/obese patients with type 2 diabetes mellitus (T2DM). A total of 159 overweight/obese patients with T2DM were randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Chao, Qiao, Qiao, Tong, Qiang, Bai, Qian, Huang, Chen, Fan, Rong, Wang, Hui, Kaliannan, Kanakaraju, Wang, Jian, Xu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501012/
https://www.ncbi.nlm.nih.gov/pubmed/34625598
http://dx.doi.org/10.1038/s41598-021-99527-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501012/
https://www.ncbi.nlm.nih.gov/pubmed/34625598
http://dx.doi.org/10.1038/s41598-021-99527-y

Ejemplares similares